Neuropathy as a potential complication of levodopa use in Parkinson's disease: a pharmacological and pharmacovigilance point of view.

Jean-Louis Montastruc; Anne Charlotte Danton; Genevieve Durrieu; Isabelle Lacroix; Pascale Olivier; Agnés Sommet; Jean-Michel Senard

doi:10.1002/mds.22878

Journal articles

Neuropathy as a potential complication of levodopa use in Parkinson's disease: a pharmacological and pharmacovigilance point of view.

Jean-Louis Montastruc ^{1, 2, *} Anne Charlotte Danton ^{1, 2} Genevieve Durrieu ^{1, 2} Isabelle Lacroix ^{1, 2} Pascale Olivier ^{1, 2} Agnés Sommet ^{1, 2} Jean-Michel Senard ^{1, 2}

* Corresponding author

1 Service de Pharmacologie Médicale

2 Faculté de Médecine

Document type :

Journal articles

Domain :

Life Sciences [q-bio] / Biochemistry, Molecular Biology

Complete list of metadata

https://www.hal.inserm.fr/inserm-00504994
Contributor : Marie Francoise Simon Connect in order to contact the contributor
Submitted on : Thursday, July 22, 2010 - 11:07:38 AM
Last modification on : Monday, July 4, 2022 - 9:07:26 AM

Neuropathy as a potential complication of levodopa use in Parkinson's disease: a pharmacological and pharmacovigilance point of view.

Links full text

Identifiers

Collections

Citation

Export

Metrics

35

Neuropathy as a potential complication of levodopa use in Parkinson's disease: a pharmacological and pharmacovigilance point of view.

Links full text

Identifiers

Collections

Citation

Export

Share

Metrics

35